X0306 4 2019-12-06 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001470015 Bernard Gordon R 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-12-04 4 S 0 1000 4.79 D 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies. Gordon R. Bernard by /s/ Michael Bonner as attorney-in-fact 2019-12-06